Tibet Cheezheng Tibetan Medicine Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Tibet Cheezheng Tibetan Medicine.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Pharmaceuticals earnings growth | 18.7% |
| Revenue growth rate | n/a |
| Future return on equity | n/a |
| Analyst coverage | None |
| Last updated | n/a |
Recent future growth updates
No updates
Recent updates
Tibet Cheezheng Tibetan Medicine (SZSE:002287) Strong Profits May Be Masking Some Underlying Issues
Nov 05
Does Tibet Cheezheng Tibetan Medicine (SZSE:002287) Have A Healthy Balance Sheet?
Oct 23Benign Growth For Tibet Cheezheng Tibetan Medicine Co., Ltd. (SZSE:002287) Underpins Its Share Price
Sep 25Tibet Cheezheng Tibetan Medicine Co., Ltd.'s (SZSE:002287) Prospects Need A Boost To Lift Shares
Jun 07Tibet Cheezheng Tibetan Medicine's (SZSE:002287) Profits May Not Reveal Underlying Issues
Apr 26Tibet Cheezheng Tibetan Medicine Co., Ltd.'s (SZSE:002287) Business And Shares Still Trailing The Market
Feb 27In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Tibet Cheezheng Tibetan Medicine has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 9/30/2024 | 2,271 | 594 | 476 | 808 | N/A |
| 6/30/2024 | 2,225 | 595 | 149 | 512 | N/A |
| 3/31/2024 | 2,114 | 586 | 429 | 684 | N/A |
| 12/31/2023 | 2,045 | 581 | 459 | 693 | N/A |
| 9/30/2023 | 1,875 | 494 | 19 | 210 | N/A |
| 6/30/2023 | 1,978 | 552 | 88 | 273 | N/A |
| 3/31/2023 | 1,933 | 478 | -134 | 95 | N/A |
| 1/1/2023 | 2,045 | 473 | 13 | 286 | N/A |
| 9/30/2022 | 1,993 | 429 | 418 | 656 | N/A |
| 6/30/2022 | 1,881 | -40 | 453 | 689 | N/A |
| 3/31/2022 | 1,849 | 700 | 733 | 915 | N/A |
| 1/1/2022 | 1,770 | 716 | 909 | 1,035 | N/A |
| 9/30/2021 | 1,657 | 727 | 304 | 555 | N/A |
| 6/30/2021 | 1,659 | 1,171 | 195 | 425 | N/A |
| 3/31/2021 | 1,662 | 458 | -178 | 48 | N/A |
| 12/31/2020 | 1,485 | 404 | -102 | 238 | N/A |
| 9/30/2020 | 1,454 | 413 | 213 | 398 | N/A |
| 6/30/2020 | 1,405 | 383 | 422 | 605 | N/A |
| 3/31/2020 | 1,301 | 328 | 634 | 801 | N/A |
| 12/31/2019 | 1,403 | 364 | 354 | 406 | N/A |
| 9/30/2019 | 1,328 | 348 | 270 | 357 | N/A |
| 6/30/2019 | 1,281 | 331 | 235 | 342 | N/A |
| 3/31/2019 | 1,240 | 326 | 199 | 315 | N/A |
| 1/1/2019 | 1,213 | 319 | 370 | 499 | N/A |
| 9/30/2018 | 1,218 | 339 | 278 | 375 | N/A |
| 6/30/2018 | 1,137 | 321 | N/A | 305 | N/A |
| 3/31/2018 | 1,086 | 309 | N/A | 297 | N/A |
| 12/31/2017 | 1,053 | 301 | N/A | 230 | N/A |
| 9/30/2017 | 1,018 | 297 | N/A | 398 | N/A |
| 6/30/2017 | 987 | 298 | N/A | 533 | N/A |
| 3/31/2017 | 971 | 294 | N/A | 381 | N/A |
| 12/31/2016 | 968 | 290 | N/A | 389 | N/A |
| 9/30/2016 | 986 | 279 | N/A | 295 | N/A |
| 6/30/2016 | 984 | 274 | N/A | 149 | N/A |
| 3/31/2016 | 1,009 | 274 | N/A | 223 | N/A |
| 12/31/2015 | 995 | 265 | N/A | 258 | N/A |
| 9/30/2015 | 984 | 252 | N/A | 350 | N/A |
| 6/30/2015 | 1,009 | 259 | N/A | 284 | N/A |
| 3/31/2015 | 979 | 243 | N/A | 277 | N/A |
| 12/31/2014 | 950 | 238 | N/A | 311 | N/A |
| 9/30/2014 | 923 | 234 | N/A | 209 | N/A |
| 6/30/2014 | 906 | 229 | N/A | 251 | N/A |
| 3/31/2014 | 907 | 218 | N/A | 256 | N/A |
| 12/31/2013 | 969 | 213 | N/A | 198 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if 002287's forecast earnings growth is above the savings rate (2.8%).
Earnings vs Market: Insufficient data to determine if 002287's earnings are forecast to grow faster than the CN market
High Growth Earnings: Insufficient data to determine if 002287's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if 002287's revenue is forecast to grow faster than the CN market.
High Growth Revenue: Insufficient data to determine if 002287's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 002287's Return on Equity is forecast to be high in 3 years time